Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer

Status unconfirmed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different doses of capecitabine in treating women who have advanced or metastatic breast cancer.

Key facts

Study ID

NCT00026442

Run by

Pharmatech Oncology

Starts

2001-11-01

Last updated by the study team

2013-12-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Antelope Valley Hospital — Lancaster, California, United States
• Medical Oncology Care Associates — Orange, California, United States
• California Cancer Medical Center — West Covina, California, United States
• Oncology Clinic, P.C. — Colorado Springs, Colorado, United States
• Hematology Oncology Associates of theTreasure Coast - Port St. Lucie — Port Saint Lucie, Florida, United States
• North Florida Cancer Center — Saint Augustine, Florida, United States
• Maryland Hematology/Oncology Associates — Baltimore, Maryland, United States
• Charleston Hematology-Oncology, P.A. — Charleston, South Carolina, United States
• Family Cancer Center — Collierville, Tennessee, United States
• Logan Regional Hospital — Logan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.